H-D-2-Nal-OH - Search Results | AbMole BioScience

About 6 results found for searched term "H-D-2-Nal-OH" (0.121 seconds)

Cat.No.	Name	Target
M39491	H-D-2-Nal-OH	Amino Acid Derivatives
	H-D-2-Nal-OH is an alanine derivative.
M14764	RTI-13951-33 hydrochloride	Others
	RTI-13951-33 hydrochloride is a potent, selective, and brain-penetrant GPR88 agonist, with an EC50 of 25 nM in GPR88 cAMP functional assay. RTI-13951-33 hydrochloride reduces alcohol reinforcement and intake behaviors in rats.
M24907	Pegbelfermin	FGFR
	BMS-986036
	Pegbelfermin (BMS-986036) is a polyethylene glycol-modified (PEGylated) analogue of human fibroblast growth factor 21 (FGF21). Pegbelfermin can be used for the research of nonalcoholic steatohepatitis (NASH).
M29847	BI‑3231	Hydroxysteroid dehydrogenase
	BI 3231 is a potent and selective hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13) inhibitor, with IC50s of 1 and 13 nM for hHSD17B13 and mHSD17B13, respectively. BI 3231 has the potential for the research of nonalcoholic steatohepatitis (NASH) and other liver diseases.
M42893	Cisd2 agonist 2	Others
	Cisd2 agonist 2 is an orally active Cisd2 activator (EC50=191 nM), while the Cisd2 levels is correlated with nonalcoholic fatty liver disease (NAFLD).
M49467	Carfloglitazar sodium	PPAR
	Chiglitazar sodium
	Carfloglitazar sodium is a dual agonist of the pan peroxisome proliferator-activated receptor (PPARα/γ) with EC50 values of 1.2, 0.08, and 1.7 μM for PPARα, PPARγ, and PPARδ, respectively.It can be used in studies related to nonalcoholic steatohepatitis (NASH).